SOCS3 promotor hypermethylation and STAT3-NF-κB interaction downregulate SOCS3 expression in human coronary artery smooth muscle cells.
about
Down-regulation of hsa-miR-1264 contributes to DNMT1-mediated silencing of SOCS3A molecular profile of cocaine abuse includes the differential expression of genes that regulate transcription, chromatin, and dopamine cell phenotype.The future of EPAC-targeted therapies: agonism versus antagonismSOCS3 Methylation Predicts a Poor Prognosis in HBV Infection-Related Hepatocellular Carcinoma.Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasisRole of Ubiquitylation in Controlling Suppressor of Cytokine Signalling 3 (SOCS3) Function and Expression.NF-κB signaling at the crossroads of inflammation and atherogenesis: searching for new therapeutic links.The relevance of epigenetics to occlusive cerebral and peripheral arterial disease.Characterization of the roles of suppressor of cytokine signaling-3 in prostate cancer development and progression.IL-23 selectively promotes the metastasis of colorectal carcinoma cells with impaired Socs3 expression via the STAT5 pathway.TNFR2 Stimulation Promotes Mitochondrial Fusion via Stat3- and NF-kB-Dependent Activation of OPA1 Expression.Methylation and microRNA-mediated epigenetic regulation of SOCS3.Epigenetics of Mucus Hypersecretion in Chronic Respiratory Diseases.Atorvastatin treatment modulates p16 promoter methylation to regulate p16 expression.Exendin-4 inhibits high-altitude cerebral edema by protecting against neurobiological dysfunction.
P2860
Q33919836-28E62A3C-4C39-4A13-8F8B-52ABEB3EE793Q33923637-9171DF83-6505-4421-8C01-6C07479AB701Q34465923-E93BBEA9-29C8-4424-A803-0643229B9229Q36184277-04CDBC72-7A7A-4666-99E7-0F819FACA0D8Q36549751-1612F155-B3CA-4BC3-8EFF-62F5292CD879Q38216732-52053BDB-2169-474C-8AF0-51C3502764FFQ38227386-7B6DE190-D246-45FD-924A-897129966AF3Q38351869-26D51C1D-DAAC-4D88-B1CF-A5409FDE4C12Q38433931-C02CD228-5A0C-4F58-B8F0-D4FAECEB3AA5Q39030466-65A0EE96-64B1-4DE7-8471-6ECEA98EBE9FQ41239818-55C728B5-C5E7-4802-9086-D9226F38627FQ41240274-25DE72E5-785C-4890-85BC-1560D074EDEBQ47725451-653C75E8-3614-479F-81FE-7F15C59E037BQ51046456-1E463839-FB2D-4BF5-960B-D9159C5A190CQ55021133-1A55772F-A7E9-412F-B208-902B573E9905
P2860
SOCS3 promotor hypermethylation and STAT3-NF-κB interaction downregulate SOCS3 expression in human coronary artery smooth muscle cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
SOCS3 promotor hypermethylatio ...... ry artery smooth muscle cells.
@ast
SOCS3 promotor hypermethylatio ...... ry artery smooth muscle cells.
@en
type
label
SOCS3 promotor hypermethylatio ...... ry artery smooth muscle cells.
@ast
SOCS3 promotor hypermethylatio ...... ry artery smooth muscle cells.
@en
prefLabel
SOCS3 promotor hypermethylatio ...... ry artery smooth muscle cells.
@ast
SOCS3 promotor hypermethylatio ...... ry artery smooth muscle cells.
@en
P2093
P2860
P1476
SOCS3 promotor hypermethylatio ...... ry artery smooth muscle cells.
@en
P2093
Devendra K Agrawal
Divya Pankajakshan
Kajari Dhar
Kriti Rakesh
P2860
P304
P356
10.1152/AJPHEART.00570.2012
P577
2013-01-18T00:00:00Z